<DOC>
	<DOCNO>NCT01978561</DOCNO>
	<brief_summary>The purpose study evaluate pregnancy , delivery , neonatal outcome subject maintain ongoing clinical pregnancy Week 10 gestation NT-03 .</brief_summary>
	<brief_title>Follow-Up Of Pregnancies Established During Study NT-03 ( Thrive-IVF Follow-Up )</brief_title>
	<detailed_description>NT-04 follow-up study include subject receive least one dose study drug maintain ongoing clinical pregnancy Week 10 gestation NT-03 . NT-04 involve administration study drug treatment . In NT-03 , subject achieve ongoing clinical pregnancy Week 8 gestation undergo repeat transvaginal ultrasound ( TVU ) Week 10 gestation ( 4 week last dose study drug ) . Subjects pregnant Week 10 gestation enrol NT-04 . Subjects NT-04 contact telephone every 6 8 week Week 38 gestation , time subject contact every two week confirmation delivery . Information pregnancy status use prescription medication collect telephone interview . Between Weeks 18 22 gestation , obstetrical ultrasound perform . Following delivery , additional information obtain , include pregnancy outcome , gestational age delivery , etc . Standardized photograph take part newborn assessment .</detailed_description>
	<criteria>At least one dose study drug administer NT03 Ongoing clinical pregnancy Week 10 gestation Able willing enroll NT04 â€¢ None</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>